The Health News USA May 10 2018
EpiPen has been recently added to the US Food and Drug Administration’s list of drug shortages due to manufacturing delays. Generic versions of Epipen along with Adrenaclick autoinjectors are all medications used to treat allergic reactions, some of which can be life-threatening.
Frequently Asked Questions
What is the main topic discussed in this episode of Health Professional Radio?
This episode covers important developments in healthcare, including updates on Medication. Health Professional Radio brings you expert insights and analysis on the latest medical news affecting healthcare professionals and patients alike.
How can healthcare professionals benefit from this information?
Healthcare professionals can stay informed about the latest developments in Medication and related fields, enabling them to provide better patient care. Staying current with medical news helps clinicians make evidence-based decisions in their practice.
Where can I find more information about Medication?
For more detailed information, listen to the full episode on Health Professional Radio and visit hpr.fm for additional resources. You can also subscribe to our podcast for regular updates on healthcare news and expert interviews.
The autoinjector allergy drug EpiPen has been recently added to the US Food and Drug Administration’s list of drug shortages due to manufacturing delays. Generic versions of Epipen along with Adrenaclick autoinjectors are all medications used to treat allergic reactions, some of which can be life-threatening. These absolute necessities for children suffering from severe allergies to counter effects such as increased or decreased heart rate, uneven breathing, swelling and other potentially fatal reactions.
The drug is distributed by Mylan but it is manufactured by a Pfizer company called Meridian Medical Technologies. However Mylan stated in a press release: “The product is available and Mylan is currently receiving continual supply from its manufacturing partner.” The company explained they are accelerating the shipment of EpiPens to wholesalers and supply levels may vary across wholesalers and pharmacies.
Pfizer said in a press release it is working to increase production of the medications as quickly as possible. The company has already asked that customers with a “medically appropriate” supply of unexpired EpiPen to be sensible when it comes to refilling additional prescriptions during the shortage so others can access the drug.
Medical Disclaimer
The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
